If youre experiencing menstrual changes while taking tirzepatide, consider asking whether your symptoms are related to weight loss, hormone fluctuations, ovulation changes, or an underlying condition such as PCOS
Hormone shifts during perimenopause and menopause, along with factors like stress, sleep, and relationship dynamics, can all influence sexual desire
current UK anaesthetic guidance advises holding GLP-1 receptor agonists for 12 weeks before surgery due to delayed gastric emptying and aspiration risk Patients should be counselled that weight loss may be slower or temporarily plateau during corticosteroid treatment, but this does not necessarily mean Wegovy should be discontinued
Common formulations from major pharmacies include 17mg/mL tirzepatide with 2mg/mL niacinamide in 4mL or 2mL vials
Retrieved November 20, 2023